Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Clinical Diffusion Neuro

Back to the Program-at-a-Glance

Clinical Diffusion Neuro
Digital Poster
Diffusion
Monday, 11 May 2026
Digital Posters Row C
09:15 - 10:10
Session Number: 362-02
No CME/CE Credit
This session examines diffusion MRI methods and applications centered on diffusion-weighted imaging and tensor-based techniques (DWI/DTI/DKI), with emphasis on microstructural characterization across neurological and systemic diseases. Presentations address diffusion tensor and kurtosis imaging, tractography-based analyses, and emerging diffusion visualization strategies, alongside longitudinal MRI frameworks supported by robust image registration. Clinical applications span multiple sclerosis, Alzheimer’s disease, traumatic brain injury, severe obstructive sleep apnea syndrome (OSAS), and IDH-mutant brain tumors. Special focus is given to diffusion-derived biomarkers such as the DTI-ALPS index and choroid plexus volume as indicators of microstructural change and fluid-related pathways. By integrating diffusion modeling, tensor imaging, and longitudinal analysis, the session highlights how diffusion MRI can reveal disease-specific trajectories and mechanisms relevant to clinical research and practice.

  Figure 362-02-001.  Reversible White Matter Microstructural Changes in Hyperthyroidism: A Diffusion Kurtosis Imaging
Mukesh Kumar, Pankaj Pankaj, Arman Deep Singh, Pawan Kumar, Poonam Rana, Tarun Sekhri, Maria D’souza, Subash Khushu
The University of Trans-Disciplinary Health Sciences and Technology, Bengaluru, India
Impact: This study highlights reversible white matter microstructural alterations in hyperthyroidism detected using DKI, linking thyroid dysfunction to cognitive deficits and demonstrating thyroxine therapy’s potential to normalize brain microstructure following restoration to the euthyroid state.
  Figure 362-02-002.  Probiotics Alters Brain Structure and Function in IBS: A Randomized Controlled Trial
Kailu Zhang, Xiaoming Liu, Wenliang Fan, Ning Zheng, Ziqiao Lei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Impact: This study provided novel in-vivo neuroimaging evidence that probiotics modulate central pathways in IBS, bridging the gap between probiotics modulation and brain function, with implications for developing targeted brain-gut axis therapies.
  Figure 362-02-003.  Time-Dependent Diffusion MRI–Based Microstructural Mapping for Predicting IDH Mutation Status in Glioma: A Multicenter Study
Wanjun Hu, Darui Li, Yuhui Xiong, Lizhi Xie, Jing Zhang
The Second Hospital & Clinical Medical School, Lanzhou, China
Impact: This study evaluated the clinical utility of td-dMRI–derived histogram features for predicting IDH mutation status. Key findings revealed significant differences in microstructural features between IDH–mutant and IDH–wildtype gliomas, supporting their potential as noninvasive imaging biomarkers for IDH identification.
  Figure 362-02-004.  Histogram analysis of QSM and DKI for identifying molecular subtypes of adult diffuse gliomas
Pengxin Shen, Yan Tan
First Hospital of Shanxi Medical University, Taiyuan, China
Impact: Noninvasive QSM and DKI histogram analysis enables early molecular profiling of gliomas, supporting individualized therapy decisions and improving prognostic evaluation for patients.
  Figure 362-02-005.  Assessment of Voxelwise Longitudinal Changes in Tissue Microstructure Measured with MAP-MRI following mTBI
Mihika Gangolli, Neil Perkins, Luca Marinelli, Peter Basser, Alexandru Avram
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD, United States of America, United States of America
Impact: Longitudinal monitoring of within-subject MAP-MRI changes may provide a more comprehensive means to study pathological alterations that evolve at multiple timepoints following mTBI, where current cross-sectional studies of image-based biomarkers lack the sensitivity and specificity to predict outcome.
  Figure 362-02-006.  Multimodal MRI Indicators of Mild Cognitive Impairment from the Cleveland Alzheimer’s Disease Research Center (CADRC)
Ken Sakaie, Katherine Koenig, Ajay Nemani, Jian Lin, Wanyong Shin, Se-hong Oh, Mark Griswold, Dan Ma, Brian Appleby, Muralidhar Pallaki, Karin Mente, Peijun Chen, Jagan Pillai, Mark Lowe
Cleveland Clinic, Cleveland, United States of America
Impact: The large effect sizes suggest that multimodal MRI has potential to serve as a biomarker for evaluating therapies before symptom onset in AD.
  Figure 362-02-007.  Mapping Neuropsychological Correlations to White Matter Organization in Individuals with and without Freezing of Gait in PD
Ivan Campbell, Gaurav Nitin Rathi, Jessica K. Caldwell, Zoltan Mari, Benjamin Hill, Virendra Mishra
University of South Alabama, Mobile, United States of America
Impact: This study demonstrates that improving sensitivity to crossing-fiber regions through fixel-based diffusion MRI uniquely captures white matter relationships with neuropsychological measures, distinguishing PD freezers from non-freezers.
  Figure 362-02-008.  Enhanced Characterization of MS Normal-Appearing White Matter: Evaluating Diffusion Complexity as a Complementary Tool to DTI
Antonio Carlos Senra Filho, Carolina Rimkus, Maria Garcia Otaduy, Andre Paschoal
University of Campinas, Campinas, Brazil
Impact: Diffusion Complexity (DC) reveals early microstructural damage in MS normal-appearing white matter, invisible to conventional DTI. This provides a new, non-redundant biomarker to monitor "hidden" disease progression and assess tissue integrity.
  Figure 362-02-009.  Glymphatic dysfunction and white-matter disruption: MRI study of chain mediation linking hydrocephalus to cognitive decline
Yawen Xiao, Jiankun Dai, Qingqing Wen, Xinlan Xiao
The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China
Impact: Our results showed glymphatic dysfunction and white-matter disruption sequentially mediate the association between ventricular dilation and cognitive decline in hydrocephalus. Our study might provide insights for facilitate early intervention and rehabilitation of cognitive decline for hydrocephalus patients.
  Figure 362-02-010.  Microstructural imaging of Glioblastoma tumours using ultra-strong gradient and multi-dimensional diffusion MRI
Muhammad Usman Akbar, Michael Law, Jennifer Golten, Najmus Sahar Iqbal, Elise Gwyther, George Eralil, Harpreet Hyare, Hannah Khirwadkar, Kathy Seddon, Matteo Figini, Eleftheria Panagiotaki, Florien Siebzehnrubl, Derek Jones, James Powell, Marco Palombo
Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom
Impact: We show first multidimensional ultra-high diffusion-weighted MRI data to characterize glioblastoma tumour microenvironment with unprecedented specificity. This non-invasive approach offers new opportunities to improve diagnosis, refine surgical margins, and track tumour response to therapy without the need for repeat biopsies.
  Figure 362-02-011.  Moderating Role of Age in the Relationship Between Immunomodulatory Factor and Brain structure in Autism Spectrum Disorder
Zhongfeng Xie
Shanghai Tenth People’s Hospital, Shanghai, China
Impact: This study aimed to investigate the effects of immunomodulatory factors on brain structure in children with autism spectrum disorder (ASD) and to explore whether these effects are moderated by age, thereby providing new insights into the biological mechanisms of ASD.
  Figure 362-02-012.  Individualized white matter mapping in pediatric drug-resistant temporal lobe epilepsy using one-vs-many diffusion MRI
Mary Aiesi, Kiran Seunarine, Yi Jie Li, Emily Drabek-Maunder, Chris Clark
University College London, London, United Kingdom
Impact: Individual-level diffusion MRI mapping of white matter microstructure in children with drug-resistant temporal lobe epilepsy reveals patient-specific abnormalities hidden by group analyses. With further work, these findings could inform preoperative evaluation and complement other clinical data to support surgical planning.
  Figure 362-02-013.  Inter-scanner harmonisation of the PREDICTOM MRI protocol
Maarten Naeyaert, Ana Beatriz Solana, Brice Fernandez, Nuno Barros, Maria Beser Robles, Thomas Janssens, Ha Young Kim, David Lythgoe, Ralph Noeske, Julie Poujol, Hubert Raeymaekers, Samir Reddigari, Manon Roose, Edina Timko, PETER VAN SCHUERBEEK, Hongxu Yang, Heiko Meyer, Suchandrima Banerjee, PREDICTOM consortium
Universitair Ziekenhuis Brussel, Brussels, Belgium
Impact: The EU-funded PREDICTOM project searches for early MRI-biomarkers for Alzheimer’s disease. The project will use scanners of different vendors and types, necessitating harmonisation. Scans on a volunteer in a single site using two vendors show reproducible quantitative MRI-parameters after harmonisation.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine